FDA Adverse Event
Injury
Summary report: N
AVELI
MDR report key: 15117895
·
Received July 27, 2022
Report
- Report Number
- 3020889437-2022-00004
- Event Type
- Injury
- Date Received
- July 27, 2022
- Date of Event
- June 21, 2022
- Report Date
- July 27, 2022
- Manufacturer
- REVELLE AESTHETICS, INC.
- Product Code
- OUP
- UDI-DI
- 00850036790006
- PMA / PMN Number
- K212399
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
IT WAS REPORTED THAT A PATIENT TREATED WITH AVÉLI DEVELOPED A SEROMA. THE SEROMA WAS DRAINED 6, 16, AND 21 DAYS AFTER THE PROCEDURE. THE PHYSICIAN WILL CONTINUE DRAINING AND WILL RECOMMEND 24/7 COMPRESSION. THE PHYSICIAN DID NOT RESPOND TO ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2332325 | AVELI | CELLULITE RELEASE DEVICE | OUP | REVELLE AESTHETICS, INC. | AVE001 | 22021702 OR 22030201 | 00850036790006 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 45 YR | Female | Required Intervention |